Clinical Trial Update: Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of Stempeucel in patients with critical limb ischemia due to thromboangiitis obliterans is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Thromboangiitis Obliterans

Drugs mentioned

• Stempeucel (mesenchymal stromal cells)

Snippet

Sponsor: Cell Biopeutics Resources Sdn Bhd | Conditions: Critical Limb Ischemia, Buerger's Disease | Phase 4 | Status: RECRUITING